Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Bicycle Therapeutics (BCYC) Assets Average (2019 - 2026)

Bicycle Therapeutics (BCYC) has disclosed Assets Average for 8 consecutive years, with $685.0 million as the latest value for Q1 2026.

  • For Q1 2026, Assets Average fell 25.57% year-over-year to $685.0 million; the TTM value through Mar 2026 reached $685.0 million, down 25.57%, while the annual FY2025 figure was $837.2 million, 7.88% up from the prior year.
  • Assets Average hit $685.0 million in Q1 2026 for Bicycle Therapeutics, down from $740.8 million in the prior quarter.
  • Across five years, Assets Average topped out at $1.0 billion in Q3 2024 and bottomed at $413.9 million in Q4 2022.
  • Average Assets Average over 5 years is $657.2 million, with a median of $617.0 million recorded in 2023.
  • Year-over-year, Assets Average surged 143.99% in 2022 and then dropped 25.57% in 2026.
  • Bicycle Therapeutics' Assets Average stood at $413.9 million in 2022, then soared by 49.08% to $617.0 million in 2023, then soared by 58.31% to $976.8 million in 2024, then fell by 24.16% to $740.8 million in 2025, then dropped by 7.53% to $685.0 million in 2026.
  • According to Business Quant data, Assets Average over the past three periods came in at $685.0 million, $740.8 million, and $798.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.